학술자료
2025-10-11 23:15:51
초기 알츠하이머병 환자에 대한 L-세린의 효과 연구
Phase IIa L-serine Trial for eAD (LSPI-2)
내용
- This is a Phase IIa, randomized, double-blind, placebo controlled trial.
- Subjects for participation in this study will be identified by the Investigator based on their Clinical Dementia Rating score which will be completed as part of standard practice.
- Patients meeting the criteria for early Alzheimer's disease will be considered for study participation, with the Investigator taking the additional inclusion/exclusion criteria into consideration.
- Up to 40 subjects will be enrolled.
- Subjects participating in the study will be randomized to receive either gummies containing L-Serine or placebo gummies, with the Investigator and study staff blinded to the group assignments.
요약
- This is a Phase IIa, randomized, double-blind, placebo controlled trial.
- Subjects for participation in this study will be identified by the Investigator based on their Clinical Dementia Rating score which will be completed as part of standard practice.
- Patients meeting the criteria for early Alzheimer's disease will be considered for study participation, with the Investigator taking the additional inclusion/exclusion criteria into consideration.
- Up to 40 subjects will be enrolled.
- Subjects participating in the study will be randomized to receive either gummies containing L-Serine or placebo gummies, with the Investigator and study staff blinded to the group assignments.
결과 해석 : 연구적 관점
- This page reorganizes publicly available research into a reference summary focused on possible functional relevance.
- Because the source is study-specific, it is useful for understanding the reported findings in context.
- Human data, when present, can inform applicability more directly.
- Functional interpretation should remain cautious because outcomes depend on design, population, and study conditions.
- It is reasonable to interpret the findings together with the broader body of evidence.
결과 해석 : 과학적 관점
- Single studies offer design clarity, but reproducibility still matters.
- Human studies improve applicability, but sample size and comparator design remain important.
- Interpretation should remain conservative when endpoints are limited or follow-up is short.
- Confidence improves when findings are consistent with related papers.
- Overall, this material is best used as a research reference rather than as a definitive functional claim.
안내
본 페이지는 공개논문, 특허, 학술자료를 바탕으로 재작성한 참고용 자료입니다.
특정 제품의 예방 또는 치료 효능을 의미하지 않습니다.
특정 제품의 예방 또는 치료 효능을 의미하지 않습니다.